A part of Watch Media

MedWatchTuesday3 October 2023

  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
MedWatchTuesday3 October 2023
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
Medtech

Pension firm: Coloplast's secret tax report could cost skilled employees

Coloplast is missing out on an advantage when recruiting and retaining skilled employees when it does not present its international tax payments, says Danish pension fund Akademikerpension, stating that transparency and trust are crucial in the competition over the best employees. (Corrected)
Photo: Coloplast / PR
Photo: Coloplast / PR
by ulrich quistgaard, translated by daniel pedersen

(Correction: An earlier version of the article stated that Akademikerpension had assessed that Coloplast could be hurt in the competition to recruit the best employees if it did not report on its tax payments on a country-by-country basis. The pension firm emphasizes that this is only the case over time if the medtech company's competition becomes more transparent, and adds that Coloplast is not suffering any recruitment losses in its current situation. The article also previously stated that Akademikerpension had attempted to push Coloplast into publicizing its national tax payments for over a year. This has been corrected, now reporting that Akademikerpension inquired whether there were any obstacles for doing so).

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Related articles:

  • Photo: Coloplast / PR

    Coloplast disappoints pension firm: "The outcome doesn't please the company, the investors or the employees"

    For subscribers

  • Coloplast has acquired a lush area of 100,000 square meters in Costa Rica, designated for two new large factories, around 20,000 square meters each. The Danish medtech company has injected around half a billion kroner (USD 76.2m) into the project so far, but tax payments in the country are nonetheless kept a secret | Photo: Coloplast/PR

    Pension companies push for Coloplast's secret Costa Rica tax report

    For subscribers

  • Coloplast does not wish to comment on the criticism of its limited transparency of its taxation outside of the EU. | Photo: Coloplast / PR

    NGO slams "hypocritical" Coloplast for keeping Costa Rica accounts secret

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Photo: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

The marketing authorization applies to children and adolescents aged 9 years and older, as well as adults with ”relatively” preserved kidney functions.
  • FDA to review Novo Nordisk drug for rare metabolic disease
  • Huge acquisition scores Novo Nordisk an FDA-ready treatment

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

For subscribers



Foto: Andrew Kelly/Reuters/Ritzau Scanpix
Pharma & biotech

Low share price may knock Galecto off the stock exchange

For subscribers


Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug


Photo: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

For subscribers


Foto: Alexander Heinl/AP/Ritzau Scanpix
Pharma & biotech

Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

For subscribers


  • Vaccine breakthrough behind mRNA shots wins Nobel Prize

    The two scientists will share the 11 million-krona ( USD 1 million) award, the Nobel Assembly at the Karolinska Institutet in Stockholm said in a statement Monday.

    For subscribers


  • Foto: Ws Audiology / Pr

    WS Audiology hires new chief technology officer from car manufacturer

    He succeeds chief research & development officer Stefan Menzl, who is stepping down after six years.

    For subscribers


  • Foto: Tom Little

    Novo Nordisk files lawsuit against US authorities ahead of price negotiation

    The litigation is the latest in a long line of industry lawsuits related to price negotiations.

    For subscribers


  • Foto: Mike Segar

    FDA rejects atopic dermatitis drug lebrikizumab

    Eli Lilly had expected a launch this year.

    For subscribers


  • The FDA has updated the package label of Novo Nordisk's diabetes drug, Ozempic, with a warning about intestinal blockage disorder as a possible side effect. | Foto: Tom Little/Reuters/Ritzau Scanpix

    FDA updates Novo Nordisk's Ozempic drug label with side effect alert

    The diabetes drug might cause a potentially fatal intestinal blockage, the authorities warn.

    For subscribers


  • Foto: Anushree Fadnavis/Reuters/Ritzau Scanpix

    Country Manager: Indians will have to wait for Wegovy until 2026

    Up to 40% of the female population aged 30-49 in India is overweight.

    For subscribers


Further reading

Photo: Tom Little
Pharma & biotech

FDA approves Novo Nordisk drug to treat rare condition

The marketing authorization applies to children and adolescents aged 9 years and older, as well as adults with ”relatively” preserved kidney functions.

For subscribers



Fujifilm Diosynth Biotechnologies' factory in Hillerød, Denmark. | Foto: Liselotte Plenov / Fotorummet / Pr
Pharma & biotech

Fujifilm expands management with former Leo executive

The contract manufacturer has hired a chief people officer with immediate effect.

For subscribers



Foto: Mike Segar/Reuters/Ritzau Scanpix
Pharma & biotech

Snack maker keeps an eye on Novo Nordisk's obesity drug

”As with anything that could potentially impact our business, we’re looking at it,” says the former Kellogg’s CEO.

Foto: Alexander Heinl/AP/Ritzau Scanpix
Pharma & biotech

Novo Nordisk's semaglutide to be studied for positive effect on alcoholics

Previous studies have shown that alcohol cravings disappeared when people were treated with GLP-1 agonist exanatide.

For subscribers



Genmab CEO Jan van de Winkel and director general of The Confederation of Danish Industry, Lars Sandahl Sørensen. | Foto: Genmab / PR
Pharma & biotech

Genmab has officially opened its new headquarters

The CEO describes the new premises as a symbol of the company’s commitment to advancing science and innovation.

For subscribers



Photo: Yuriko Nakao/Reuters/Ritzau Scanpix
Medtech

Olympus appoints new chief medical officer

The new medical director is brought in from Medtronic. 

For subscribers


Jobs

  • Clinical Trial Manager

  • Senior QA Specialists (GMP or GCP)

  • Scientist - Bioanalysis, Biologics

  • Qualified Person to AJ Vaccines

  • Global Medical Manager

  • Clinical Supply Manager

  • Senior Legal Councel

  • QA/RA Manager

  • Audit & Supplier Manager

  • Supply Value Stream (SVS) Project Manager

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Director, Head of Antibody Technology

  • Senior Analytical Scientists

See all jobs

Latest news

  • Novo Nordisk's semaglutide to be studied for positive effect on alcoholics –
  • Olympus appoints new chief medical officer –
  • Low share price may knock Galecto off the stock exchange –
  • Fujifilm expands management with former Leo executive –
  • Snack maker keeps an eye on Novo Nordisk's obesity drug –
  • FDA approves Novo Nordisk drug to treat rare condition –
  • FDA updates Novo Nordisk's Ozempic drug label with side effect alert –
  • FDA rejects atopic dermatitis drug lebrikizumab –
  • FDA to support new orphan drugs through pilot program –
  • Vaccine breakthrough behind mRNA shots wins Nobel Prize –
See all

Jobs

  • Clinical Trial Manager

  • Senior QA Specialists (GMP or GCP)

  • Scientist - Bioanalysis, Biologics

  • Qualified Person to AJ Vaccines

  • Global Medical Manager

  • Clinical Supply Manager

  • Senior Legal Councel

  • QA/RA Manager

  • Audit & Supplier Manager

  • Supply Value Stream (SVS) Project Manager

  • VP of Software Development, Perfusion Tech

  • Project Director, HR & ESG

  • Senior CMC Specialist, Upstream Processing, Genmab

  • Director, Head of Antibody Technology

  • Senior Analytical Scientists

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

  • About MedWatch

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Banner Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved